Organisation paid for research Program year 2023 Source: CMS Open Payments

LSU Pennington Biomedical Research

Neither a doctor nor a teaching hospital

Research payments

$635,070

1,046 payments

Through program year 2023, LSU Pennington Biomedical Research is reported as receiving $635,070 in research payments, across 1,046 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$66,971	355
2022	Research	$5,944	7
2021	Research	$122,748	240
2020	Research	$266,764	365
2019	Research	$172,643	79

Breakdown

Who paid Research payments · program years 2019–2023

Novo Nordisk AS $521,024 1,040 payments
AstraZeneca AB $78,000 1 payment
AstraZeneca Pharmaceuticals LP $35,579 3 payments
Novartis Pharmaceuticals Corporation $467 2 payments

Studies the money was for Research payments · program years 2019–2023

Nn9536-4576 $223,582 282 payments
Nn9536-4376 $147,957 34 payments
A Phase IIb Randomised Parallel Double Blind Placebo Controlled and Open Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects with Type 2 Diabetes Mellitus $87,080 2 payments
Nn9536-4512 $66,288 353 payments
Nn9924-4437 $30,137 209 payments
AMETHYST Congestive Heart Failure CHF Heart Failure Therapy Area Cardiovascular, Renal and Metabolism $26,499 2 payments
Nn8022-4180 $19,711 3 payments
Nn8022-4392 $17,343 133 payments
Nn9924-4635 $16,006 26 payments
A 12 Week Randomized Patient and Investigator Blinded Placebo Controlled Parallel Group Study to Investigate the Efficacy of Lik066 in Obese Patients With Non Alcoholic Steatohepatitis Nash $417 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.